194 related articles for article (PubMed ID: 33619611)
1. Botulinum Toxin Versus Placebo: A Meta-Analysis of Treatment and Quality-of-life Outcomes for Hyperhidrosis.
Obed D; Salim M; Bingoel AS; Hofmann TR; Vogt PM; Krezdorn N
Aesthetic Plast Surg; 2021 Aug; 45(4):1783-1791. PubMed ID: 33619611
[TBL] [Abstract][Full Text] [Related]
2. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
Naumann M; Lowe NJ; Kumar CR; Hamm H;
Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
[TBL] [Abstract][Full Text] [Related]
3. Effect of botulinum toxin type A on quality of life measures in patients with excessive axillary sweating: a randomized controlled trial.
Naumann MK; Hamm H; Lowe NJ;
Br J Dermatol; 2002 Dec; 147(6):1218-26. PubMed ID: 12452874
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Safety and Efficacy of Botulinum Toxin A Treatment in Adolescent Patients with Axillary Bromhidrosis.
Wang T; Dong J; He J
Aesthetic Plast Surg; 2018 Apr; 42(2):560-564. PubMed ID: 29344685
[TBL] [Abstract][Full Text] [Related]
6. A Phase 3, Randomized, Multi-center Clinical Trial to Evaluate the Efficacy and Safety of Neu-BoNT/A in Treatment of Primary Axillary Hyperhidrosis.
Lee DG; Kim JE; Lee WS; Kim MB; Huh CH; Lee YW; Choi GS; Lee JB; Yu DS; Shin MK; Roh MR; Ahn HH; Kim WS; Lee JH; Park KY; Park J; Lee WJ; Park MY; Kang H
Aesthetic Plast Surg; 2022 Jun; 46(3):1400-1406. PubMed ID: 35132458
[TBL] [Abstract][Full Text] [Related]
7. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
Güleç AT
J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
[TBL] [Abstract][Full Text] [Related]
8. Interventions for hyperhidrosis in secondary care: a systematic review and value-of-information analysis.
Wade R; Rice S; Llewellyn A; Moloney E; Jones-Diette J; Stoniute J; Wright K; Layton AM; Levell NJ; Stansby G; Craig D; Woolacott N
Health Technol Assess; 2017 Dec; 21(80):1-280. PubMed ID: 29271741
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of Botulinum Toxin Injection on Bruxism: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Chen Y; Tsai CH; Bae TH; Huang CY; Chen C; Kang YN; Chiu WK
Aesthetic Plast Surg; 2023 Apr; 47(2):775-790. PubMed ID: 36694050
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin type A in the treatment of bilateral primary axillary hyperhidrosis: efficacy and duration with repeated treatments.
Lowe PL; Cerdan-Sanz S; Lowe NJ
Dermatol Surg; 2003 May; 29(5):545-8. PubMed ID: 12752526
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxins for the prevention of migraine in adults.
Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
[TBL] [Abstract][Full Text] [Related]
12. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.
Campanati A; Penna L; Guzzo T; Menotta L; Silvestri B; Lagalla G; Gesuita R; Offidani A
Clin Ther; 2003 Jan; 25(1):298-308. PubMed ID: 12637128
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A in treatment of bilateral primary axillary hyperhidrosis: randomised, parallel group, double blind, placebo controlled trial.
Naumann M; Lowe NJ
BMJ; 2001 Sep; 323(7313):596-9. PubMed ID: 11557704
[TBL] [Abstract][Full Text] [Related]
14. Botulinum Toxin A Plays an Important Role in the Placement of Implants Deep Within the Pectoralis Major Muscle for Mammaplasty: A Systematic Review and Meta-analysis.
Li T; Liu Y; Zhang W
Aesthetic Plast Surg; 2018 Dec; 42(6):1519-1530. PubMed ID: 30083802
[TBL] [Abstract][Full Text] [Related]
15. C-Arm Guided Percutaneous Radiofrequency Thoracic Sympathectomy for Treatment of Primary Palmar Hyperhidrosis in Comparison with Local Botulinum Toxin Type A Injection, Randomized Trial.
Mostafa TAH; Hamed AA; Mohammed BM; El Sheikh NA; Shama AAA
Pain Physician; 2019 Nov; 22(6):591-599. PubMed ID: 31775406
[TBL] [Abstract][Full Text] [Related]
16. Treatment of focal idiopathic hyperhidrosis with Botulinum Toxin Type A: clinical predictive factors of relapse-free survival.
Campanati A; Sandroni L; Gesuita R; Giuliano A; Giuliodori K; Marconi B; Ganzetti G; Offidani A
J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):917-21. PubMed ID: 21054569
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Botulinum Toxin A in Axillary Bromhidrosis and Associated Histological Changes in Sweat Glands: A Prospective Randomized Double-Blind Side-by-Side Comparison Clinical Study.
Wu CJ; Chang CK; Wang CY; Liao YS; Chen SG
Dermatol Surg; 2019 Dec; 45(12):1605-1609. PubMed ID: 30829777
[TBL] [Abstract][Full Text] [Related]
18. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis.
Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J
Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543
[TBL] [Abstract][Full Text] [Related]
19. Treatment of focal hyperhidrosis with botulinum toxin type A: long-term follow-up in 61 patients.
Schnider P; Moraru E; Kittler H; Binder M; Kranz G; Voller B; Auff E
Br J Dermatol; 2001 Aug; 145(2):289-93. PubMed ID: 11531794
[TBL] [Abstract][Full Text] [Related]
20. Long-term quantitative benefits of botulinum toxin type A in the treatment of axillary hyperhidrosis.
Odderson IR
Dermatol Surg; 2002 Jun; 28(6):480-3. PubMed ID: 12081675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
